Treatment of vancomycin-resistant staphylococcal infections

Annals of Pharmacotherapy

Volumn 30, Issue 3, 1996, Pages 288-290

  Christensen, Keith J ^a   Gubbins, Paul O ^b  

^a UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION;

EID: 0029997598     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000313     Document Type: Article

References (17)

1. Herwalt L, Boyken L, Pfaller M. In vitro selection of vancomycin in bloodstream isolates to Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis 1991;10:1007-12.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):S72-5.
3. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States. 1980-1989. Am J Med 1991:91(suppl 3B):S86-9.
4. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987;316:927-31.
5. Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis 1990;161:45-51.
6. Froggatt JW, Johnston JL, Galetto DW, Archer GL. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother 1989;33:460-6.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A3. Villanova, PA: National Committee for Clinical Laboratory Standards, 1984.
8. Jackson MA, Hicks RA. Vancomycin failure in staphylococcal endocarditis. Pediatr Infect Dis J 1987;6:750-2.
9. Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J Antimicrob Chemother 1991;27:71-9.
10. Shales DM, Binczewski B, Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 1993;17(suppl 2):S527-36.
11. Uttley AH, George RC, Nadu J, Woodford N, Johnson AP, Collins CH, et al. High level vancomycin-resistant enterccocci causing hospital infections. Epidemiol Infect 1989;103:173-81.
12. Leclercq R, Derlot E, Weber M, Duvall J, Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989;33:10-5
13. Noble WC, Virani Z, Cree R. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis. NCTC12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992;93:195-8.
14. Aubert G, Passot S, Lucht F, Dorche G. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemalyticus during teicoplanin treatment of Staphylococcus epidermidis infection. J Antimicrob Chemother 1990;25:491-3.
15. Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol 1990;28:2064-8.
16. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-13.
17. Shales DM Vancomycin-resistant bacteria. Infect Control Hosp Epidemiol 1992;13:193-4.